Dominique L Braun Selected Research

Weight Gain

11/2021

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique L Braun Research Topics

Disease

19	Infections 11/2022 - 01/2015
6	HIV Infections (HIV Infection) 06/2022 - 11/2014
3	Syphilis 01/2019 - 01/2017
2	Hepatitis C 11/2022 - 01/2015
2	Hypertension (High Blood Pressure) 01/2022 - 11/2021
2	COVID-19 01/2022 - 08/2021
2	Persistent Infection 01/2022 - 10/2019
1	Viremia 01/2022
1	Insulin Resistance 11/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2021
1	Weight Gain 11/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 10/2018
1	Chronic Hepatitis C 01/2018
1	Hepatitis B 08/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2015
1	Coinfection 01/2015
1	Fibrosis (Cirrhosis) 01/2015
1	Disease Progression 01/2014
1	Acute Retroviral Syndrome 01/2014

Drug/Important Bio-Agent (IBA)

5	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 08/2016
4	Broadly Neutralizing AntibodiesIBA 01/2022 - 11/2016
3	Pharmaceutical PreparationsIBA 01/2022 - 10/2018
3	AntibodiesIBA 01/2022 - 08/2016
3	AntigensIBA 08/2021 - 01/2018
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2022 - 01/2015
2	dolutegravirIBA 11/2021 - 10/2019
2	Antiviral Agents (Antivirals)IBA 10/2021 - 01/2018
2	NucleotidesIBA 01/2019 - 11/2014
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017 - 08/2016
1	MacrolidesIBA 06/2022
1	Moxifloxacin (Avelox)FDA Link 06/2022
1	VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	NucleosidesIBA 01/2022
1	Reverse Transcriptase InhibitorsIBA 01/2022
1	IntegrasesIBA 01/2022
1	Integrase InhibitorsIBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Raltegravir Potassium FDA Link 11/2021
1	tenofovir alafenamideIBA 11/2021
1	grazoprevirIBA 01/2019
1	EnzymesIBA 01/2019
1	LipidsIBA 01/2019
1	elbasvirIBA 01/2019
1	InterferonsIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Biological ProductsIBA 06/2017
1	Nevirapine (Viramune)FDA Link 01/2017
1	Viral AntigensIBA 11/2016
1	Silybin (Lagosa)IBA 01/2015
1	Ribavirin (Virazole)FDA LinkGeneric 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2014

Therapy/Procedure

6	Therapeutics 01/2022 - 01/2015
4	Art Therapy 01/2022 - 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 10/2019